Testing New Method of Analyzing MR Images
Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.
|Study Design:||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
|Official Title:||Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI|
- To provide preliminary data for a larger study that this type of imaging can be used to monitor the effectiveness of anti-angiogenic therapy. [ Time Frame: After analysis of images ] [ Designated as safety issue: No ]
|Study Start Date:||March 2008|
|Study Completion Date:||July 2010|
|Primary Completion Date:||July 2010 (Final data collection date for primary outcome measure)|
The purpose of this study is to develop and evaluate new MR imaging techniques and protocols for non-invasive monitoring of anti-angiogenesis treatment of breast cancer. This is a preliminary imaging study to test this imaging protocol on subjects already undergoing MR for clinical purposes.
The specific objective of this research study is to develop and validate both MRI and functional MRI data acquisition methods, task paradigms, and post-processing techniques to ensure reliability of results.
The information derived from this research is intended to be applied to a future study of subjects undergoing experimental anti-angiogenesis drug therapy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00630318
|United States, Indiana|
|Indianapolis, Indiana, United States, 46202|
|Principal Investigator:||Susan E. Clare, MD, Ph.D.||Indiana University|